Predicting Grade and Patient Survival in Renal Cancer Using Machine Learning Analysis of Nucleolar Prominence
Cancer Medicine · 2025
DOI: 10.1002/cam4.71196 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Elena Ivanova und 16 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Regenerative Medicine, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia. Hauptthemen laut MEDLINE: Kidney Neoplasms, Machine Learning, Carcinoma, Renal Cell, Cell Nucleolus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation.
Abstract (Originalsprache)
Background
Patients with clear cell renal cell carcinoma (ccRCC) often undergo organ resection, with treatment strategies based on recurrence risk. Current metastatic potential assessments rely on the WHO/ISUP grading system, which is subject to interobserver variability.
Methods
We developed an artificial intelligence (AI) model to classify cells according to contemporary grading rules and evaluated the prognostic significance of tumor cell profiles, particularly focusing on cells with prominent nucleoli.
Results
The model accurately distinguished low (G1/G2) and high (G3/G4) grades, achieving an area under the ROC curve of 0.79. Survival analysis identified four tissue patterns defined by total cell density and the proportion of cells with prominent nucleoli. The relative abundance of such cells had greater prognostic value than their mere presence, correlating with survival times ranging from 2.2 to over 6 years. Additionally, we confirmed that dystrophic changes and focal necrosis are linked to shorter survival.
Conclusion
These findings suggest that incorporating refined criteria into the WHO/ISUP system could enhance its prognostic accuracy in future revisions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Regenerative Medicine, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
- B.V.Petrovsky Russian Research Center of Surgery, Moscow, Russia.
- World-Class Research Center "Digital Biodesign and Personalized Healthcare, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
- PJSC VimpelCom, Moscow, Russia.
- Scientific and Educational Resource Center, Peoples' Friendship University of Russia, Moscow, Russia.
- Institute of Clinical Morphology and Digital Pathology, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
ORCID-Profile: Alexey Fayzullin
Förderung
- Ministry of Science and Higher Education of the Russian Federation
Zitieren
APA
Ivanova, E., Fayzullin, A., Grinin, V., Zhavoronkov, D., Ermilov, D., Balyasin, M., Timakova, A., Bakulina, A., Osmanov, Y., Rudenko, E., Arutyunyan, A., Parchiev, R., Shved, N., Astaeva, M., Lychagin, A., Demura, T., & Timashev, P. (2025). Predicting Grade and Patient Survival in Renal Cancer Using Machine Learning Analysis of Nucleolar Prominence. Cancer Medicine. https://doi.org/10.1002/cam4.71196
Vancouver
Ivanova E, Fayzullin A, Grinin V, Zhavoronkov D, Ermilov D, Balyasin M, et al. Predicting Grade and Patient Survival in Renal Cancer Using Machine Learning Analysis of Nucleolar Prominence. Cancer Medicine. 2025. doi:10.1002/cam4.71196
BibTeX
@article{Ivanova2025,
author = {Ivanova, Elena and Fayzullin, Alexey and Grinin, Victor and Zhavoronkov, Dmitry and Ermilov, Dmitry and Balyasin, Maxim and Timakova, Anna and Bakulina, Alesia and Osmanov, Yusif and Rudenko, Ekaterina and Arutyunyan, Alexander and Parchiev, Ruslan and Shved, Nina and Astaeva, Marina and Lychagin, Aleksey and Demura, Tatiana and Timashev, Peter},
title = {Predicting Grade and Patient Survival in Renal Cancer Using Machine Learning Analysis of Nucleolar Prominence},
journal = {Cancer Medicine},
year = {2025},
doi = {10.1002/cam4.71196}
}
EUVIMED